About: Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Sector: Healthcare
Industry: Biotechnology
Latest price: $253.00 (+1.38%)
ASND NASDAQ Ascendis Pharma AS
Ascendis Pharma AS share price
Atividade de preço de ASND
Último preço
$ 253,000
Variação (24h)
3,45 USD (1,38%)
Volume
491.01K
Volume (média 4 sem.)
-
Abertura
$ 250,62
Variação do dia
$ 249,56 - $ 254,20
Fechamento anterior
$ 249,55
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ASND price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals